Saturday, June 18, 2016 11:04:13 PM
When questioned, the DEA lawyer felt compelled to admit the truth to our reporter, because he had told the lawyer representing a DEA informant of the DEA's intentions: Pot will become legal nationwide on August 1, 2016.
"Whatever the law may be in California, Arizona or Utah or any other State, because of Federal preemption this will have the effect of making THC products legal with a prescription, in all 50 states," the DEA attorney told the Observer. Federal Preemption is a doctrine that where the US Government regulates a particular field, State and local laws are overridden and of no effect.
He explained that "there are five DEA schedules. Nothing on Schedule One is ever legal, and that is where Cannabis is today. Schedule Two drugs are available with a prescription."
On Schedule Two, marijuana will join drugs like Percocet, Xanax, Oxycontin, Abilify and other drugs that are legal, even common, with a prescription. There also other drugs that are not on any schedules but that are illegal on a federal level, he said. Drugs like aspirin and ibuprofen are available over-the-counter.
He opined that the 135 medicinal cannabis clinic owners in Los Angeles will no doubt oppose this move by the Federal government, because the rule change will eliminate any reason for people to visit medical marijuana clinics. "In my opinion, CVS pharmacy, Rite-Aid and Walgreens will sell Schedule Two THC products similar to what users call "edibles," but will not sell smokable weed because of the health risk smoking anything entails," said the DEA lawyer.
The Los Angeles based DEA Attorney who spoke to us, asked to remain anonymous because he was not authorized to speak to the press about the matter. He speculated that this action will be taken in the closing days of the 2016 U.S. Presidential election, so as to motivate the Democratic base to turn out and vote for Hillary Clinton, and other down ballot candidates. She will certainly not reverse this policy decision taken in the waning days of the Barack Obama administration, he said. But Donald Trump might.
"Marijuana enforcement is a big drain on DEA resources," he said was another reason for the change, noting that a majority of the American public favor the legalization of marijuana for medical use.
Libertarian candidate Gary Johnson is in favor of legalizing marijuana and in fact owns a business which pedals pot in New Mexico.
California will vote on November 7th, 2016, whether to legalize the recreational use of marijuana. Because of Federal preemption, the DEA's reclassification of cannabis as a Schedule Two drug, will have the legal effect of requiring a prescription in California--i.e., it will continue the status quo.
Since the Golden State legalized medical marijuana almost 20 years ago, Federal authorities have occasionally raided medical marijuana clinics here. They have forced major banks, like Bank of America, to close clinic bank accounts. The Feds have even seized real estate belonging to landlords who rent space to pot clinics. The Federal war on medicinal marijuana will abruptly end on August 1, 2016.
8/01 is the new 4/20!
Medical cannabis, or medical marijuana, can refer to the use of cannabis and its cannabinoids to treat disease or improve symptoms; However, there is no single agreed upon definition, says Wikipedia. The use of cannabis as a medicine has not been rigorously scientifically tested, often due to production restrictions and other governmental regulations. There is limited evidence suggesting cannabis can be used to reduce nausea and vomiting during chemotherapy, to improve appetite in people with HIV/AIDS, and to treat chronic pain and muscle spasms. Its use for other medical applications, however, is insufficient for conclusions about safety or efficacy.
Recent AMMJ News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/01/2024 09:05:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/01/2023 05:23:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2023 05:27:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 06:30:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2023 01:42:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/03/2023 08:08:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/28/2023 06:36:07 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 09/21/2023 04:33:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/07/2023 03:40:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/05/2023 08:17:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/29/2023 09:07:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/29/2023 08:54:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/29/2023 08:46:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/29/2023 08:37:45 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/24/2023 05:51:49 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:02:42 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM